CN Patent

CN108623520A — 阿立哌唑缩醛月桂酸酯的制备方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2018-10-09 · 8y expired

What this patent protects

本发明涉及一种制备阿立哌唑缩醛月桂酸酯即（7‑（4‑（4‑（2,3二氯苯基）‑1‑哌嗪基）丁氧基）‑2‑氧‑3,4‑二氢喹啉‑1（2H）‑基）甲基月桂酸酯的方法，该方法采用月桂酸酰氯代替月桂酸酐，经4‑二甲氨基吡啶催化，不但可以提高收率，减少副产物的生成，提高产品纯度，还可以缩短反应时间，操作简便，降低成本，适合工业化生产。

USPTO Abstract

本发明涉及一种制备阿立哌唑缩醛月桂酸酯即（7‑（4‑（4‑（2,3二氯苯基）‑1‑哌嗪基）丁氧基）‑2‑氧‑3,4‑二氢喹啉‑1（2H）‑基）甲基月桂酸酯的方法，该方法采用月桂酸酰氯代替月桂酸酐，经4‑二甲氨基吡啶催化，不但可以提高收率，减少副产物的生成，提高产品纯度，还可以缩短反应时间，操作简便，降低成本，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108623520A
Jurisdiction
CN
Classification
—
Expires
2018-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.